Clinical Trial Update: High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose cholecalciferol with chemotherapy and bevacizumab as first-line therapy for metastatic colorectal cancer was terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Stage IV Colon Cancer, Stage IV Rectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-21